Impact of cow's milk allergy on enterocolitis associated with Hirschsprung's disease

Satoshi Umeda1, Hisayoshi Kawahara, Akihiro Yoneda

  • 1Department of Pediatric Surgery, Osaka Medical Center and Research Institute for Maternal and Child Health, 840 Murodo-cho Izumi, Osaka, 594-1101, Japan, s_umeda3104@yahoo.co.jp.

Insights

Cow's milk allergy (CMA) may increase the risk of postoperative enterocolitis in infants with Hirschsprung's disease (HD). Further research is needed to confirm this association in pediatric surgery patients.

Area of Science:

  • Pediatric Surgery
  • Gastroenterology
  • Allergy Immunology

Background:

  • Hirschsprung's disease (HD) is a congenital condition affecting the large intestine.
  • Cow's milk allergy (CMA) is common in infants and can cause gastrointestinal distress.

Purpose of the Study:

  • To investigate the potential impact of cow's milk allergy (CMA) on infants diagnosed with Hirschsprung's disease (HD).

Main Methods:

  • A cohort of 24 infants undergoing HD surgery was divided into two groups: those with (Group B, n=14) and without (Group A, n=10) CMA indicators.
  • CMA was determined by lymphocyte stimulation tests and eosinophilic infiltration in resected colon tissue.
  • Clinical and laboratory data were compared between the two groups.

Main Results:

  • No pre- or postoperative enterocolitis was observed in infants without CMA (Group A).
  • Infants with possible CMA (Group B) experienced a higher incidence of postoperative enterocolitis compared to Group A (p=0.04).
  • No significant differences were found in other clinical or laboratory parameters between the groups.

Conclusions:

  • Cow's milk allergy (CMA) may represent a risk factor for developing postoperative enterocolitis in infants with Hirschsprung's disease (HD).
  • This finding suggests a potential link between allergic reactions and complications following HD surgery.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...